Strategic footprint Bilim İlaç operates two major production sites in Turkey with approvals from both the German and UK health authorities, indicating a strong GMP foundation and potential for multi-market manufacturing partnerships or contract manufacturing opportunities.

Scale and reach With 1001-5000 employees, annual revenue over $10B, and exports to 70+ countries, Bilim İlaç demonstrates substantial global distribution capacity and willingness to expand or co-market high-demand pharmaceutical products.

R&D and innovation Home to Turkey’s largest pharmaceutical R&D center (4,500 square meters) and a focus on new product development, presenting opportunities for collaboration on innovative dosage forms, generics, or specialty medicines.

Regulatory readiness ISO 45001 certified with SAP and ABAP expertise suggests robust operations, enabling conversations about supply chain resilience, digitalization, and compliant regional expansions leveraging their existing ERP and quality systems.

Export-driven partnerships Established export footprint and regional offices in Moldova and Albania signal openness to channel partnerships, distributor agreements, or regional co-development initiatives to accelerate market entry.